Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of Toronto

$105,000.00

Modulation of NKT cell function by Nod signaling: role in the development of asthma

EF 2008-09

Résumé
T cells are immune cells, lymphocytes, which respond to a prolonged infection. NK T cells are innate lymphocytes that respond quickly to infection and share markers common to natural killer cells, another innate immune cell. Invariant natural killer T (iNKT) cells are a subset within NK T cells that express a particular receptor, Valpha14-Jalpha8 TCR alpha chain, which bind the MHC 1 like-related molecule, CD1d. When NK T cells recognize a cell presenting the CD1d, plus lipid, they are activated and release inflammatory molecules. Another unique characteristic of iNKT cells is that they produce inflammatory molecules capable of directing different immune responses, i.e. humoral (Th2) or cellular response (Th2). The signaling for iNKT cell activation is not clear but preliminary work suggests that ligands for the nucleotide-binding oligomerization domain (Nod) proteins stimulate IFN-gamma production. Nod proteins are receptors which can peptidoglycan, a component of bacterial cell walls. Studies from our laboratory have suggested that defective Nod1 signaling may drive abnormal Th2 responses. This dysregulation is associated with inflammatory diseases, e.g. asthma and inflammatory bowel disease. iNKT cells can function to skew adaptive immunity toward Th2 responses or directly act as effector cells at mucosal surfaces. iNKT cells have also been implicated in asthma. Our hypothesis is that Nod protein dysregulation impacts on iNKT cell function leading to the development of abnormal inflammation. Preliminary work suggests iNKT cells can be induced to produce small but significant amounts of IFN-gamma, an inflammatory molecule, in vitro by DCs stimulated with NOD ligands. In vitro studies will be performed by isolating NKT cells from the liver, stimulating these cells in vitro by Nod ligands and then analyzing for activation. In vivo studies will be carried out through stimulation of wild-type mice with NOD ligands and analysis of iNKT cell function.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
184420
Name
Selvanantham Thirumahal
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Modulation of NKT cell function by Nod signaling: role in the development of asthma
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Asthma; Innate Natural Killer T (Inkt) Cells; Nucleotide Oligomerization Domain (Nod) Receptors
Abstract
T cells are immune cells, lymphocytes, which respond to a prolonged infection. NK T cells are innate lymphocytes that respond quickly to infection and share markers common to natural killer cells, another innate immune cell. Invariant natural killer T (iNKT) cells are a subset within NK T cells that express a particular receptor, Valpha14-Jalpha8 TCR alpha chain, which bind the MHC 1 like-related molecule, CD1d. When NK T cells recognize a cell presenting the CD1d, plus lipid, they are activated and release inflammatory molecules. Another unique characteristic of iNKT cells is that they produce inflammatory molecules capable of directing different immune responses, i.e. humoral (Th2) or cellular response (Th2). The signaling for iNKT cell activation is not clear but preliminary work suggests that ligands for the nucleotide-binding oligomerization domain (Nod) proteins stimulate IFN-gamma production. Nod proteins are receptors which can peptidoglycan, a component of bacterial cell walls. Studies from our laboratory have suggested that defective Nod1 signaling may drive abnormal Th2 responses. This dysregulation is associated with inflammatory diseases, e.g. asthma and inflammatory bowel disease. iNKT cells can function to skew adaptive immunity toward Th2 responses or directly act as effector cells at mucosal surfaces. iNKT cells have also been implicated in asthma. Our hypothesis is that Nod protein dysregulation impacts on iNKT cell function leading to the development of abnormal inflammation. Preliminary work suggests iNKT cells can be induced to produce small but significant amounts of IFN-gamma, an inflammatory molecule, in vitro by DCs stimulated with NOD ligands. In vitro studies will be performed by isolating NKT cells from the liver, stimulating these cells in vitro by Nod ligands and then analyzing for activation. In vivo studies will be carried out through stimulation of wild-type mice with NOD ligands and analysis of iNKT cell function.
Competitiondate
200810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Selvanantham, Thirumahal
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~